These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 23222301)

  • 1. TLRs as miRNA receptors.
    Fabbri M
    Cancer Res; 2012 Dec; 72(24):6333-7. PubMed ID: 23222301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. microRNAs in the tumor microenvironment: solving the riddle for a better diagnostics.
    Challagundla KB; Fanini F; Vannini I; Wise P; Murtadha M; Malinconico L; Cimmino A; Fabbri M
    Expert Rev Mol Diagn; 2014 Jun; 14(5):565-74. PubMed ID: 24844135
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toll-like receptors and immune regulation: implications for cancer therapy.
    Wang RF; Miyahara Y; Wang HY
    Oncogene; 2008 Jan; 27(2):181-9. PubMed ID: 18176599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interplay between microRNAs, Toll-like receptors, and HIV-1: potential implications in HIV-1 replication and chronic immune activation.
    Swaminathan G; Navas-Martín S; Martín-García J
    Discov Med; 2014; 18(97):15-27. PubMed ID: 25091485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small RNAs have a large impact: circulating microRNAs as biomarkers for human diseases.
    Weiland M; Gao XH; Zhou L; Mi QS
    RNA Biol; 2012 Jun; 9(6):850-9. PubMed ID: 22699556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Application of microRNAs to Cancer Therapy].
    Iguchi H; Ochiya T
    Gan To Kagaku Ryoho; 2010 Mar; 37(3):389-95. PubMed ID: 20332672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new role for microRNAs, as ligands of Toll-like receptors.
    Fabbri M; Paone A; Calore F; Galli R; Croce CM
    RNA Biol; 2013 Feb; 10(2):169-74. PubMed ID: 23296026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miRNAs: possible regulators of toll like receptors and inflammatory tumor microenvironment in colorectal cancer.
    Matboli M; Hossam N; Farag D; Hassan M; Shehata H; Aboelhussein M; Ismail N; Eissa S
    BMC Cancer; 2024 Jul; 24(1):824. PubMed ID: 38987740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression and function of toll-like receptors in multiple myeloma patients: toll-like receptor ligands promote multiple myeloma cell growth and survival via activation of nuclear factor-kappaB.
    Xu Y; Zhao Y; Huang H; Chen G; Wu X; Wang Y; Chang W; Zhu Z; Feng Y; Wu D
    Br J Haematol; 2010 Sep; 150(5):543-53. PubMed ID: 20629663
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(I:C) reduces expression of JAM-A and induces secretion of IL-8 and TNF-α via distinct NF-κB pathways in human nasal epithelial cells.
    Ohkuni T; Kojima T; Ogasawara N; Masaki T; Fuchimoto J; Kamekura R; Koizumi J; Ichimiya S; Murata M; Tanaka S; Himi T; Sawada N
    Toxicol Appl Pharmacol; 2011 Jan; 250(1):29-38. PubMed ID: 20932985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance.
    Cherfils-Vicini J; Platonova S; Gillard M; Laurans L; Validire P; Caliandro R; Magdeleinat P; Mami-Chouaib F; Dieu-Nosjean MC; Fridman WH; Damotte D; Sautès-Fridman C; Cremer I
    J Clin Invest; 2010 Apr; 120(4):1285-97. PubMed ID: 20237413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and immunological activities of novel Toll-like receptor 7 and 8 agonists.
    Kandimalla ER; Struthers M; Bett AJ; Wisniewski T; Dubey SA; Jiang W; Precopio M; Sun Z; Wang H; Lan T; Agrawal S; Casimiro DR
    Cell Immunol; 2011; 270(2):126-34. PubMed ID: 21570062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple signaling pathways contribute to synergistic TLR ligand-dependent cytokine gene expression in human monocyte-derived macrophages and dendritic cells.
    Mäkelä SM; Strengell M; Pietilä TE; Osterlund P; Julkunen I
    J Leukoc Biol; 2009 Apr; 85(4):664-72. PubMed ID: 19164128
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interplay Between Exosomes, microRNAs and Toll-Like Receptors in Brain Disorders.
    Paschon V; Takada SH; Ikebara JM; Sousa E; Raeisossadati R; Ulrich H; Kihara AH
    Mol Neurobiol; 2016 Apr; 53(3):2016-2028. PubMed ID: 25862375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Micromanagement during the innate immune response.
    Dahlberg JE; Lund E
    Sci STKE; 2007 May; 2007(387):pe25. PubMed ID: 17519424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancers take their Toll--the function and regulation of Toll-like receptors in cancer cells.
    Chen R; Alvero AB; Silasi DA; Steffensen KD; Mor G
    Oncogene; 2008 Jan; 27(2):225-33. PubMed ID: 18176604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNAs in breast cancer pathogenesis.
    Götte M
    Minerva Ginecol; 2010 Dec; 62(6):559-71. PubMed ID: 21079577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor stimulation in cardiomyoctes decreases contractility and initiates an NF-kappaB dependent inflammatory response.
    Boyd JH; Mathur S; Wang Y; Bateman RM; Walley KR
    Cardiovasc Res; 2006 Dec; 72(3):384-93. PubMed ID: 17054926
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MicroRNomics: a newly emerging approach for disease biology.
    Zhang C
    Physiol Genomics; 2008 Apr; 33(2):139-47. PubMed ID: 18303086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNAs as molecular biomarkers of cancer.
    Fabbri M
    Expert Rev Mol Diagn; 2010 May; 10(4):435-44. PubMed ID: 20465498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.